We are live on
!
Find out more
Balyasny Asset Management Portfolio holdings
AUM
$77.1B
1-Year Est. Return
42.89%
This Fund
S&P 500
This Quarter
Est. Return
+7.96%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$78.8B
AUM Growth
-$135M
(-0.17%)
Cap. Flow
-$4.13B
Cap. Flow
% of AUM
-5.25%
Top 10 Holdings %
Top 10 Hldgs %
14.64%
Holding
3,669
New
809
Increased
1,002
Reduced
1,102
Closed
643
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$807M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$497M |
| 3 |
RNAM
Avidity Biosciences
RNAM
|
+$390M |
| 4 |
Kenvue
KVUE
|
+$379M |
| 5 |
Broadcom
AVGO
|
+$324M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$409M |
| 2 |
Visa
V
|
+$354M |
| 3 |
Advanced Micro Devices
AMD
|
+$328M |
| 4 |
Meta Platforms (Facebook)
META
|
+$317M |
| 5 |
Lockheed Martin
LMT
|
+$316M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.61% |
| 2 | Consumer Discretionary | 9.64% |
| 3 | Healthcare | 8.17% |
| 4 | Industrials | 8.1% |
| 5 | Financials | 8.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1576
NNN REIT
NNN
$8.87B
| $3.22M | ﹤0.01% |
+81,272
| New | +$3.33M |
|
1577
PUT
Vertex Pharmaceuticals
VRTX
$131B
| $3.22M | ﹤0.01% |
+7,100
| New | +$3.06M |
|
1578
Equillium
EQ
$127M
| $3.22M | ﹤0.01% |
2,076,250
+72,602
| +4% | +$88.4K |
|
1579
Loar Holdings
LOAR
$6.93B
| $3.22M | ﹤0.01% |
47,287
+29,831
| +171% | +$2.17M |
|
1580
The GEO Group
GEO
$4B
| $3.21M | ﹤0.01% |
199,004
-225,883
| -53% | -$3.77M |
|
1581
Gildan
GIL
$10.6B
| $3.2M | ﹤0.01% |
51,243
+40,917
| +396% | +$2.43M |
|
1582
New Jersey Resources
NJR
$5.64B
| $3.2M | ﹤0.01% |
+69,302
| New | +$3.2M |
|
1583
Winmark
WINA
$1.26B
| $3.2M | ﹤0.01% |
7,891
+4,329
| +122% | +$1.85M |
|
1584
PUT
Northrop Grumman
NOC
$81.6B
| $3.19M | ﹤0.01% |
+5,600
| New | +$3.25M |
|
1585
Mobileye
MBLY
$7.57B
| $3.19M | ﹤0.01% |
305,855
-2,462,687
| -89% | -$30.8M |
|
1586
PUT
Norfolk Southern
NSC
$75.9B
| $3.18M | ﹤0.01% |
+11,000
| New | +$3.18M |
|
1587
PUT
Vistra
VST
$49.1B
| $3.16M | ﹤0.01% |
19,600
-41,200
| -68% | -$7.5M |
|
1588
PUT
United Rentals
URI
$69.7B
| $3.16M | ﹤0.01% |
3,900
+1,700
| +77% | +$1.48M |
|
1589
Invesco Senior Income Trust
VVR
$459M
| $3.15M | ﹤0.01% |
+962,302
| New | +$3.18M |
|
1590
Chubb
CB
$133B
| $3.14M | ﹤0.01% |
10,064
+3,921
| +64% | +$1.15M |
|
1591
First Citizens BancShares
FCNCA
$25.6B
| $3.13M | ﹤0.01% |
+1,460
| New | +$2.75M |
|
1592
Ulta Beauty
ULTA
$22.2B
| $3.12M | ﹤0.01% |
5,165
-115,111
| -96% | -$63.3M |
|
1593
Abeona Therapeutics
ABEO
$361M
| $3.12M | ﹤0.01% |
+591,737
| New | +$2.98M |
|
1594
Visteon
VC
$2.86B
| $3.11M | ﹤0.01% |
+32,702
| New | +$3.46M |
|
1595
PUT
Bilibili
BILI
$7.14B
| $3.11M | ﹤0.01% |
126,400
+66,100
| +110% | +$1.78M |
|
1596
EPAM Systems
EPAM
$5.24B
| $3.11M | ﹤0.01% |
15,157
-140,217
| -90% | -$25M |
|
1597
Arvinas
ARVN
$589M
| $3.1M | ﹤0.01% |
261,756
-945,511
| -78% | -$10.3M |
|
1598
CVB Financial
CVBF
$4.08B
| $3.09M | ﹤0.01% |
166,009
+151,519
| +1,046% | +$2.9M |
|
1599
PUT
Rigetti Computing
RGTI
$6.21B
| $3.07M | ﹤0.01% |
138,700
-352,600
| -72% | -$11.5M |
|
1600
Cosan
CSAN
$2.57B
| $3.07M | ﹤0.01% |
776,592
+761,968
| +5,210% | +$3.47M |
|
Similar funds
BC
Balyasny Asset Management's Q4 2025 Portfolio in Review
As of Q4 2025, Balyasny Asset Management held 3,669 positions worth $78.8B, down 0.17% from $78.9B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Balyasny Asset Management withdrew a net $4.13B in Q4 2025, closing 643 positions and reducing 1,102 holdings. Its most notable exit was Mr. Cooper, an estimated $277M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Balyasny Asset Management opened a new position in Avidity Biosciences worth $436M.
- Balyasny Asset Management's largest Q4 2025 buy was Avidity Biosciences: 6,040,590 shares worth $436M.
- Balyasny Asset Management added most to Amazon in Q4 2025, an estimated $807M increase.
- Balyasny Asset Management's biggest Q4 2025 reduction was Apple, cutting an estimated $409M.
- Balyasny Asset Management fully exited Mr. Cooper in Q4 2025, selling an estimated $277M.
- Balyasny Asset Management's ten largest holdings make up 15% of its $78.8B portfolio in Q4 2025.
- Balyasny Asset Management opened 809 new positions and closed 643 in Q4 2025.
- Balyasny Asset Management's portfolio value fell 0.17% quarter-over-quarter to $78.8B.
Based on Balyasny Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.